Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT

Joshua A. Hill, W. Garrett Nichols, Francisco M. Marty, Genovefa A. Papanicolaou, Thomas M. Brundage, Randall Lanier, Danielle M. Zerr, Michael J. Boeckh

Blood (2020) 135 (17): 1447–1451.

https://doi.org/10.1182/blood.2019004315

Published: 2020

Includes: Supplemental data

Journal Articles

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

Blood (2015) 126 (18): 2153–2161.

https://doi.org/10.1182/blood-2015-05-645986

Published: 2015

Includes: Supplemental data

Journal Articles

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Michael Boeckh, W. Garrett Nichols

Blood (2004) 103 (6): 2003–2008.

https://doi.org/10.1182/blood-2003-10-3616

Published: 2004

Journal Articles

Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment

Corey Casper, W. Garrett Nichols, Meei-Li Huang, Lawrence Corey, Anna Wald

Blood (2004) 103 (5): 1632–1634.

https://doi.org/10.1182/blood-2003-05-1721

Published: 2004

Journal Articles

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

Kieren A. Marr, Fulvio Crippa, Wendy Leisenring, Maggie Hoyle, Michael Boeckh, S. Arunmozhi Balajee, W. Garrett Nichols, Benjamin Musher, Lawrence Corey

Blood (2004) 103 (4): 1527–1533.

https://doi.org/10.1182/blood-2003-08-2644

Published: 2004

Journal Articles

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

Martin Bornhäuser, Barry Storer, John T. Slattery, Frederick R. Appelbaum, H. Joachim Deeg, John Hansen, Paul J. Martin, George B. McDonald, W. Garrett Nichols, Jerald Radich, Ann Woolfrey, Andreas Jenke, Eberhard Schleyer, Christian Thiede, Gerhard Ehninger, Claudio Anasetti

Blood (2003) 102 (3): 820–826.

https://doi.org/10.1182/blood-2002-11-3567

Published: 2003

Journal Articles

Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions

W. Garrett Nichols, Thomas Price, Michael Boeckh

Blood (2003) 101 (12): 5091–5092.

https://doi.org/10.1182/blood-2003-03-0780

Published: 2003

Journal Articles

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

W. Garrett Nichols, Thomas H. Price, Ted Gooley, Lawrence Corey, Michael Boeckh

Blood (2003) 101 (10): 4195–4200.

https://doi.org/10.1182/blood-2002-10-3143

Published: 2003

Journal Articles

Cytomegalovirus infections in cancer patients receiving granulocyte transfusions

W. Garrett Nichols, Thomas Price, Michael Boeckh

Blood (2002) 99 (9): 3483–3484.

https://doi.org/10.1182/blood.V99.9.3483

Published: 2002

Journal Articles

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

W. Garrett Nichols, Lawrence Corey, Ted Gooley, Chris Davis, Michael Boeckh

Blood (2001) 98 (3): 573–578.

https://doi.org/10.1182/blood.V98.3.573

Published: 2001

Journal Articles

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

W. Garrett Nichols, Lawrence Corey, Ted Gooley, W. Lawrence Drew, Richard Miner, Meei-Li Huang, Chris Davis, Michael Boeckh

Blood (2001) 97 (4): 867–874.

https://doi.org/10.1182/blood.V97.4.867

Published: 2001

NARROW

Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

Cytomegalovirus infections in cancer patients receiving granulocyte transfusions

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only